CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress
The main aim of the challenge is to encourage early-stage start-ups and individuals working on innovations in Ayurveda and other alternative healing and medicine systems
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
The HD-550 endoscopy system has been available outside of the USA since 2019
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
Subscribe To Our Newsletter & Stay Updated